Infinity Pharmaceuticals
Devon Jones has extensive experience in the nursing field, currently serving as a Utilization Management Nurse Consultant at Aetna Life Insurance Company since March 2011 and as a Registered Nurse at Independence Plus, INC. since August 2009. With a Master's of Science in Nursing Education obtained from the University of Phoenix between 2011 and 2015, Devon Jones combines clinical expertise with a strong focus on nursing education.
This person is not in any offices
Infinity Pharmaceuticals
Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.